as 07-18-2025 4:00pm EST
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Founded: | 1983 | Country: | United States |
Employees: | N/A | City: | BIRMINGHAM |
Market Cap: | 12.3B | IPO Year: | 1986 |
Target Price: | $123.38 | AVG Volume (30 days): | 978.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 4.84 | EPS Growth: | 30.58 |
52 Week Low/High: | $82.74 - $123.13 | Next Earning Date: | 08-04-2025 |
Revenue: | $5,512,600,000 | Revenue Growth: | 11.21% |
Revenue Growth (this year): | 10.75% | Revenue Growth (next year): | 8.59% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Tarr Mark J | EHC | President & CEO | May 20 '25 | Sell | $121.24 | 118,384 | $14,387,152.06 | 645,360 | |
COLTHARP DOUGLAS E | EHC | EVP & Chief Financial Officer | Apr 29 '25 | Sell | $115.55 | 43,575 | $5,017,537.68 | 77,671 | |
Darby John Patrick | EHC | EVP, Gen Counsel & Secretary | Apr 29 '25 | Sell | $114.79 | 10,000 | $1,147,900.00 | 79,710 |
EHC Breaking Stock News: Dive into EHC Ticker-Specific Updates for Smart Investing
Zacks
22 days ago
Zacks
23 days ago
Argus Research
24 days ago
Barchart
25 days ago
StockStory
a month ago
Zacks
a month ago
Zacks
a month ago
Zacks
a month ago
The information presented on this page, "EHC Encompass Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.